Resident Poster

(9-001) Evaluating the Impact of Health-Related Social Needs Training on Healthcare Professions Students Knowledge, Confidence, and Perceptions

(9-002) Closing the RSV Immunization Gap: Using the RE-AIM Framework to Assess a Pharmacy-Led Initiative

(9-003) Identifying Women’s Health Services Needs in a Self-Insured Employee Population

(9-004) Assessment of Appropriate Total Parenteral Nutrition Use and Initiation within a Community Health System

(9-005) Medication Use Evaluation of Crotalidae Polyvalent Immune Fab (Ovine) (Crofab®)

(9-006) Fighting Rabies at First Bite: A Medication Use Evaluation of Rabies Immune Globulin Administration and Dosing in the Emergency Department

(9-007) Evaluating the Impact of Clinical Pharmacist Involvement within a Multidisciplinary Antiretroviral Clinic on Human Immunodeficiency Virus Management in a Federally Qualified Health Center

(9-008) Evaluating Hemoglobin A1C Outcomes in an Interdisciplinary Diabetes Clinic With Pharmacist Integration

(9-012) Evaluating Post-Discharge Antibiotic Overuse in Uncomplicated Community-Acquired Pneumonia and Urinary Tract Infections

(9-013) Evaluation of Postoperative Outcomes and the Impact of an Enhanced Recovery Pathway in Patients who have Undergone a Laparotomy Procedure

(9-014) Evaluation of Revisions to Pharmacist-Directed Heparin Infusion Protocol

(9-015) Evaluation of Albumin Use in the Pediatric Intensive Care Unit

(9-016) Evaluation of Safety and Efficacy Outcomes for Patients with Carbapenem-Resistant Pseudomonas aeruginosa Infections Treated with Cefepime or Piperacillin-Tazobactam in a Large Community Hospital

(9-017) Evaluation of Tenecteplase for Acute Ischemic Stroke at a Large Community Hospital

(9-018) Medication Use Evaluation of Droperidol in the Emergency Department at a Large Community Hospital

(9-019) Evaluation of Direct Oral Anticoagulant (DOAC) Lead-In Dosing in Oncology Patients with Venous Thromboembolism

(9-020) Evaluation of Updated ICU Adult Diabetic Ketoacidosis (DKA) Orders at a Large Community Hospital

(9-021) Evaluation of valproic acid versus quetiapine adjunct use for acute agitation in patients receiving continuous sedation

(9-022) Paclitaxel infusion reaction evaluation and prevention strategies at a large community hospital outpatient chemotherapy infusion center

(9-023) Clinical Outcomes of Patients with Presumed Clostridioides difficile Colonization in a Large Community Hospital

(9-024) Evaluating the Utility of Routine Weekly Doppler Ultrasound Screening in Trauma Patients

(9-025) Comparing Safety and Efficacy of Subcutaneous Unfractionated Heparin Dosing Frequencies for Venous Thromboembolism Prophylaxis in a Community Hospital

(9-026) Outcomes Associated with Early Versus Late Infectious Disease Consult for Staphylococcus aureus Bacteremia

(9-027) Antimicrobial Prescribing Practices for Community-Acquired Pneumonia (CAP) in a Community, Teaching Health System

(9-028) Opioid Utilization with Enhanced Recovery After Cesarean Delivery Protocol Versus Standard of Care

(9-029) Evaluation of the Medication Discrepancy Rate at Discharge

(9-030) Assessment of Pharmacist Adherence to AUC-Guided Vancomycin Dosing in Patients with Normal Renal Function

(9-031) Medication Use Evaluation of Gentamicin Use as Surgical Prophylaxis in Cesarean Section Deliveries

(9-032) Pharmacist Perspectives of Artificial Intelligence (AI)

(9-033) Impact of pharmacist- driven protocol on utilization of Methicillin- Resistant Staphylococcus aureus (MRSA) nasal polymerase chain reaction (PCR) for pneumonia or sepsis with respiratory source

(9-034) Ceftriaxone Treatment Failure in Serratia marcescens: A Single-Center Retrospective Review of Clinical Outcomes and Predictors

(9-035) Retrospective analysis of clinical outcomes using ideal body weight phenobarbital dosing in alcohol withdrawal syndrome among body mass index cohorts

(9-036) Barriers to Immunization: Arizona Pharmacists' Perspectives on Enhancing Vaccine Delivery in Community Settings

(9-037) Retrospective Review of Clinical Outcomes with Different Initial Doses of Centruroides Immune F(ab’)₂ (Equine) for Scorpion Envenomation

(9-038) Empiric Carbapenem-Sparing Treatment of Infected Necrotizing Pancreatitis

(9-039) Insulin Regular Versus Insulin Lispro for the Treatment of Hyperkalemia in Adults with Renal Dysfunction

(9-040) Evaluation of Corticosteroid Therapy for Post-extubation Stridor and Re-intubation

(9-041) Evalutation of Simplified Administration Rates for Potassium Replacement in Patients with Diabetic Ketoacidosis

(9-042) A Retrospective Evaluation of Adjunct Medications Given During the Management of Bark Scorpion Envenomation in the Pediatric Population

(9-043) Prescribed Steroid Bursts as an Indicator of Chronic Obstructive Pulmonary Disease and Asthma Control: A Retrospective Chart Review

(9-044) Incidence and Outcomes of Hospitalized Patients Receiving Parenteral Nutrition Who Develop Candidemia: A Retrospective Chart Review

(9-045) Title: Incidence of acute respiratory distress syndrome among mechanically ventilated non-cardiac surgery patients receiving chlorhexidine

(9-046) Discordance Rates in Drug Dosing of Commonly Utilized Antimicrobial Agents in Extremes of Body Mass Index Using Various Equations to Estimate Glomerular Filtration (eGFR)

(9-047) Impact of Buprenorphine Initiation Strategy on Withdrawal Symptom Control: A Retrospective Review

(9-048) Evaluation of Cefepime Utilization and De-Escalation at a Rural Medical Center

(9-049) Dapagliflozin Utilization in Patients with Heart Failure at a Rural Hospital

(9-050) Evaluation of Pharmacist Order Verification Alerts at a Community Teaching Hospital

(9-051) Assessment of Short Term Outcomes Following Single-dose IL-2 Receptor Agonist Induction in Lung Transplant Recipients

(9-052) Restricted Versus Standard Intravenous Fluid Administration in Elective Gastrointestinal Outpatient Procedures

(9-053) Evaluation of barriers to obtaining accurate medication histories in a community hospital

(9-054) Evaluating the Impact of a Pharmacist-Led Collaborative Practice Agreement on Clinical and Operational Outcomes in Oncology Services

(9-055) Efficacy of Liposomal Bupivacaine in Erector Spinae Plane Blocks for Cardiothoracic Surgery: a Retrospective Review

(9-056) Retrospective Analysis of Outcomes Following Implementation of a Geriatric Pain Management Order Set

(9-057) The Role of Phenobarbital Versus Benzodiazepines in Patients with Alcohol Withdrawal Syndrome

(9-058) Retrospective Evaluation of Two Types of Factor Products for Management of Perioperative Bleeding in Cardiac Surgery

(9-059) Evaluation of Duplicate Orders for As Needed Indications After Policy Changes

(9-060) Impact of Scheduled Muscle Relaxants on Opioid Utilization in Adults with Rib Fractures: A Retrospective Cohort Study

(9-061) Iron Sucrose Use at Kingman Regional Medical Center

(9-062) Describing Prescribing Practices for Cosyntropin Testing

(9-063) Pharmacist-led Pediatric Asthma Clinic: Improving Asthma Control in Pediatric Patients at a Rural Federally Qualified Health Care Center

(9-064) Optimizing Anticoagulation Clinic: Impact of converting warfarin patients to direct oral anticoagulants or home INR monitoring services, while assessing clinic capacity for new service expansion.

(9-065) Implementation of a Pharmacist-supported Transition of Care (TOC) Process within an Ambulatory Care Setting

(9-066) Evaluation of Gabapentin Use for Alcohol Withdrawal in a Rural Community Hospital

(9-067) Analysis of Meds to Beds Programming Impact on Post-Psychiatric Hospitalization Discharge Patient Outcomes

(9-068) Impact of Pharmacist- versus Prescriber-administered Long-acting Injectables on Patient Adherence and Persistence

(9-069) Improving Medication Outcomes in Patients with Chronic Conditions Through Proactive Financial Assistance in Home Delivery Pharmacy Services

(9-070) Effectiveness of Enhanced Adherence Program for Chronic Medications on Patient Outcomes and Pharmacy Satisfaction

(9-071) Impact of Spanish-Speaking Pharmacy Call Center on Operational and Clinical Outcomes

(9-072) Evaluating the Impact of Drive-Up and Go Prescription Pickup Services on Patient Perception of Medication Adherence

(9-073) Effectiveness of Short-Course Mollicute Prophylaxis Post-Lung Transplantation

(9-074) A single center review of euglycemic diabetic ketoacidosis in patients taking SGLT2 inhibitors

(9-075) Implementation of Pharmacogenomic Testing to Guide Antiplatelet Therapy in Patients Prescribed Clopidogrel at Sun Life Health

(9-076) Impact of Clinical Pharmacy Diabetes Management on Diabetes-Related Medicare Star Metrics

(9-077) Utilizing Interventions to Address Barriers in Reporting Medication Errors in Pediatric Units

(9-078) Exploring Methods to Enhance Inventory Management Efficiency in Automated Dispensing Units

(9-079) Retrospective Analysis Comparing Efficacy of Extended Infusion Piperacillin-Tazobactam, Standard Infusion Piperacillin-Tazobactam, and Ceftriaxone Plus Metronidazole in the Treatment of Perforated Appendicitis in Children

(9-080) Evaluating Alaris Smart Pump Alerts to Improve Adverse Drug Event Reporting at Tucson Medical Center

(9-081) Comparison of Polyethylene Glycol -Electrolyte Solution vs Polyethylene Glycol 3350 with Sports Drink for Adequate Bowel Preparation at Valleywise Health

(9-082) Retrospective Review of Phenobarbital Dosing Strategies for Acute Alcohol Withdrawal at Valleywise Health Medical Center.

(9-083) Impact of Automated Insulin Delivery on Glycemic Outcomes in Adults with Type 2 Diabetes Mellitus (T2DM) in a Rural Federally Qualified Health Center (FQHC) Setting

(9-084) Characterizing Clinical Pharmacy Performed Medication Reconciliation as Part of Integrated Medication-Assisted Treatment Visits

(9-085) Evaluation of Area Under the Curve (AUC) vs Trough-Based Vancomycin Monitoring in Pediatric Patients at a Children’s Hospital

(9-086) Comparison of Early vs. Late Steroid Initiation and its Impact on In-Hospital Mortality in Septic Shock Patients

(9-087) Evaluating Impact of Education Interventions on Completing Guideline Based Care Prior to Transfer in Patients with Sepsis

(9-088) Evaluation of Nitrofurantoin Use for Urinary Tract Infections in the Emergency Department

(9-089) Guideline-Based Assessment of Anaerobic Coverage in Community-Acquired Pneumonia

(9-090) Evaluating the Efficacy of Droperidol Compared to Second Generation Antipsychotics In the Management of Acute Agitation In the Emergency Department

(9-091) Evaluation of Outcomes Following Treatment with Ibuprofen, Indomethacin, or Acetaminophen for PDA Closure in Preterm Infants at a Level III NICU

(9-092) Evaluating Heart Failure Readmission Rates After Pharmacist-Led Medication Education

(9-093) Evaluating appropriate use and cost-savings of dalbavancin in the NEA Baptist Memorial Emergency Department

(9-094) Identifying Risk Factors for Treatment Failure with Oral Vancomycin in Initial Clostridioides difficile Infection to Support First-Line Fidaxomicin Use

(9-095) Assessing the Correlation of Perinatal Health and Incidence of Preterm Labor Rates in Pregnant Women with Hypertensive Disorders of Pregnancy in a Community Hospital

(9-096) Incidence of Hypotension with Ketamine versus Etomidate in Rapid Sequence Intubation

(9-097) Impact of Pharmacist-led Patient Education on Hospital Readmission Rates Among Patients Admitted with Hyperglycemic Emergencies in a Rural Hospital Setting

(9-098) Epidemiology of Postoperative Infections at Unity Health-White County Medical Center

(9-099) Evaluating the Impact of Retail-Based Wellness Events on Preventive Health Engagement and Immunization Uptake

(9-100) Effect of GLP-1 Agonists on INR in Patients on Warfarin

(9-101) Evaluating the Impact of Central Fill on Clinical Services in Community Pharmacies

(9-102) Assessing Community Pharmacist Comfort and Willingness to Provide Long-Acting Injectable Medications for Opioid Use Disorder (MOUD)

(9-103) Evaluating Cost Savings and Health Benefits for Pharmacy Patients Engaged with Pharmacy Health Application

(9-104) Impact of a Revised Alcohol Withdrawal Order Set in Non-Critically Ill Patients

(9-105) Impact of GFR vs. creatinine clearance for cefepime dosing in critically ill patients with impaired renal function

(9-106) Pharmacist-Directed Evaluation of Artificial Intelligence–Generated Recommendations to Enhance Guideline-Directed Medical Therapy in Heart Failure

(9-107) Evaluating the Impact of Normal Saline Infusion with Calaspargase on Infusion Reaction Rates

(9-108) Daratumumab for Desensitization in Pediatric Heart Transplant Candidates

(9-109) Use of Methocarbamol in Infants Post-Neurosurgery: A Case Series

(9-110) Efficacy and Safety of Fixed Versus Weight-Based Factor Eight Inhibitor Bypassing Activity (FEIBA) for Apixaban or Rivaroxaban Associated Intracranial Hemorrhage

(9-111) Evaluating prescribing practices of rivaroxaban and apixaban for the treatment of venous thromboembolism among patients with renal dysfunction

(9-112) Serum Procalcitonin and Absolute Neutrophil Count as a Rule-Out Test to Reduce Invasive Procedures and Antibiotic Exposure in Neonates: A Retrospective Cohort Study

(9-113) Evaluating the Impact of Pharmacist-Led Education for Healthcare Providers on Appropriate Sepsis Management

(9-114) Evaluation of Meropenem Administration in Hospitalized Patients: Initiation Practices and Strategies to Mitigate Inappropriate Use

(9-115) Vancomycin versus Linezolid in MRSA Pneumonia and SSTIs: Evaluation of Guideline Implementation and Comparative Outcomes Before and After Linezolid Adoption

(9-116) Fixed Versus Weight-Based Kcentra Dosing for Anticoagulation Reversal: A Pre-Post Implementation Study of Utilization, Effectiveness, and Safety

(9-117) Evaluating the Substitution of vancomycin to linezolid for Pneumonia and Skin and Soft Tissue Infections

(9-118) Reducing Concurrent Opioid and Benzodiazepine Prescribing at Hospital Discharge: A Quality Improvement Initiative

(9-119) Boosting Best Practices: Aligning Emergency Department Discharge Prescriptions with Urinary Tract Infection Guidelines

(9-120) Review of Turnaround Time for First-Dose Antibiotic Administration in Adult and Neonatal Intensive Care Unit Patients with Sepsis

(9-121) Incidence of Neutropenic Adverse Events and Complications associated with Antibody-Drug Conjugate Therapy

(9-122) Clevidipine versus Nicardipine for Blood Pressure Management in Acute Ischemic Stroke Patients Eligible for Tenecteplase

(9-123) Dosing Regimen Comparison of a Pharmacy Vancomycin Trough-Based Dosing Protocol versus a Bayesian AUC:MIC-Guided Dosing Calculator in a Community Teaching Hospital

(9-124) Retrospective Review of Flat-Dosing Versus Weight-Based Dosing Rasburicase in Managing Tumor Lysis Syndrome-related Hyperuricemia

(9-125) Safety and Efficacy: Pharmacist-led DKA protocol

(9-127) Metformin as an Adjunct to Antibiotic Therapy in Sepsis: A Retrospective Cohort Study at a Tertiary Care Center

(9-128) Evaluation of Hypoglycemia Rates in the Management of Hyperkalemia in the Inpatient Setting

(9-129) Safety Outcomes of Valproate Administered by Intravenous Push Compared with Intravenous Piggyback in Adults

(9-130) Impact of First Fill Implementation on Medication Safety and Patient Adherence

(9-131) Integrating Pharmacists in Dual Antidepressant Therapy Management

(9-132) Colectomy Outcomes with Liposomal Bupivacaine

(9-133) Retrospective Study Comparing the Relapse Rate of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia After Front-Line Tyrosine Kinase Inhibitors

(9-134) Evaluation of the Use of High-Dose vs. Low-Dose Insulin for Hyperkalemia in the Emergency Department

(9-135) Evaluation of Vancomycin Associated Nephrotoxicity After Implementation of Bayesian Dose Optimizing Software in a Community Hospital

(9-136) Implementation of a Pharmacy-Compounded Alteplase 1mg/2mL for Central Venous Catheter Occlusions to Cost Saving Initiative

(9-137) Prolonged infusion of β-lactam antibiotics for pediatric patients with ventriculoperitoneal shunt infections.

(9-138) Opportunities for Urine Testing Diagnostic and Antimicrobial Stewardship in Emergency Department Discharge Patients at Palomar Health

(9-139) Evaluating the Efficacy of Oral Vancomycin Prophylaxis Criteria Expansion in C. difficile infection Prevention

(9-140) Comparative Risk of Intracranial Hemorrhage After Tenecteplase, Thrombectomy, and Alteplase in Acute Ischemic Stroke at a certified stroke center, Palomar Medical Center

(9-141) Evaluating Phenobarbital Dosing Strategies for Alcohol Withdrawal Syndrome in the Emergency Department and New Inpatient Hospital Admissions

(9-142) Streamlining Inpatient Diabetes Management: Developing PowerPlans and Procedures for Hybrid Closed Loop Systems (HCLS) and Automatic Insulin Delivery (AID) Systems

(9-143) Prospective Fluoroquinolone Prescribing Review and Its Impact on Readmission and Resistance at a Community Hospital

(9-144) Evaluating Real-World Effectiveness and Adherence of Glucagon-Like Peptide-1 Receptor Agonists in Adults with Type 2 Diabetes at a Safety-Net Hospital

(9-145) Evaluation of Time to Therapeutic Activated Partial Thromboplastin Time (aPTT) in Patients Who Received Continuous Unfractionated Heparin After Target Range Changes in a Community Hospital

(9-146) Efficacy and Safety of Remdesivir in Immunocompromised versus Immunocompetent Patients

(9-147) Impact of a Buprenorphine Protocol on Managing Opioid Use Disorder in a Community Hospital

(9-148) Clinical Utility of MRSA Nares Screening to optimize Empiric Antibiotic Therapy in Pneumonia

(9-149) Outcomes of Low-dose Four Factor Prothrombin Complex Concentrate in the Peri- and Post-operative Setting

(9-150) Sedative Use and its Impact on Short Term Outcomes in Newborn Infants Receiving Therapeutic Hypothermia

(9-151) Use of Intramuscular Ziprasidone and Intramuscular Diphenhydramine with Intramuscular Lorazepam or Intramuscular Midazolam in the Management of Acute Agitation in a Psychiatric Care Facility

(9-152) Association Between Early and Delayed Oral Antipsychotic Administration and Subsequent Intramuscular Use in a Psychiatric Emergency Department: A Retrospective Study

(9-153) Sodium Bicarbonate in the Management of Diabetic Ketoacidosis

(9-154) Multicenter Retrospective Evaluation of CroFab Versus ANAVIP for Snake Envenomation in Southern California

(9-155) Impact of Long-Acting Injectable Antipsychotics on 30-day and 90-day Readmission Rates in Adolescent Patients

(9-157) Evaluation of Inpatient Intravenous Chemotherapy Utilization and Financial Impact

(9-158) Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Health Outcomes Project Evaluation (HOPE): Examining Pharmacy Prescription Dispensing and Patient Refill Patterns

(9-159) Evaluation of the Use of Phenobarbital and Benzodiazepines in Alcohol Withdrawal Syndrome and Impact on CIWA Scores

(9-160) Pharmacist-Driven Interventions to Optimize Angiotensin II Usage

(9-161) Evaluation of a Pharmacist-Led Transitions of Care (TOC) Program With an Emphasis on Discharge Counseling in a Post Ischemic Stroke Patient Population.

(9-162) Treatment Tolerance and Disease Relapse/Progression Among CP-CML Patients Treated With Second-Generation TKIs in the First-Line Setting

(9-163) Evaluation of Optimized Post-Acute Coronary Syndrome Discharge Regimens on 90-Day Hospital Readmission

(9-164) Evaluating the Impact of Staff Education and Pharmacist Intervention on Optimizing Postoperative Nausea and Vomiting Therapy Regimens in Surgical Patients at an Acute Care Hospital

(9-165) Evaluation of Sedation Practices and Risk Factors Associated with Self-Extubation in Mechanically Ventilated Patients

(9-166) Effect of Pharmacist-Led Interventions on Metabolic Outcomes in Individuals Treated with Atypical Antipsychotics

(9-167) Impact of Isavuconazonium Levels on Fungal Infections in Lung Transplant Recipients

(9-168) Impact of Immunoglobulin G Levels on Pulmonary Infections After Lung Transplantation

(9-169) Impact of Post-Discharge Transitions of Care Pharmacist Integration in Primary Care Clinics

(9-170) Evaluation of Intravenous Labetalol for Heart Rate Control in Patients Who Present with Acute Aortic Dissection in the Emergency Department

(9-171) Assessing the cost effectiveness of switching antifungal prophylaxis in cardiothoracic transplantation

(9-172) Impact of Shortened Perioperative Antibiotic Regimen in Lung Transplant

(9-173) Evaluating Outcomes of a Clinical Pharmacy Program with Community Provider Groups

(9-174) Towards Better Urinary Tract Infection Management: Predictors of Resistance and Treatment Gaps After Emergency Department Care

(9-175) PIVOT II: Pharmacist Interventions to Improve Value and Optimize Therapy at Specialty Pharmacy

(9-176) Impact of Rapid Vancomycin Target Attainment

(9-177) Hypoglycemic Risk with Reduced Insulin Regimen for Hyperkalemia Treatment in Patients with Renal Insufficiency

(9-178) Impact of Anti-Thymocyte Globulin (rATG) Induction Therapy vs. No Induction on Liver Transplant Outcomes: A single-center retrospective analysis

(9-179) Evaluation of accuracy of mandatory documentation of antibiotic indication when prescribing by electronic orders in the acute care setting

(9-180) Impact of Pharmacist-Led Targeted Stewardship on Carbapenem Use at a Multi-Campus Acute Care Hospital

(9-181) Real-World Evaluation of Donanemab Use in Adults with Early Alzheimer’s Disease within an Integrated Healthcare System

(9-182) Evaluation of Updated Stress Ulcer Prophylaxis Protocol Implementation in Critically Ill Patients

(9-183) Analyzing the effects of long-acting insulin overlap and the recurrence of Diabetic Ketoacidosis in the Pediatric Intensive Care Unit of Sutter Medical Center Sacramento

(9-184) Evaluation of Vancomycin Dosing and Monitoring in Pediatric Patients Per Pediatric Pharmacy Kinetic Protocols

(9-185) More or Less – Effect of Anti-Thymocyte Globulin Dose on Risk of Acute Graft Rejection and Opportunistic Infection in Kidney Transplant Recipients

(9-186) Boosting RSV Vaccine Uptake: How Pharmacist Education Wins Patients Over During the 2025-2026 Flu Season

(9-187) Interdisciplinary Delivery of Basic Ambulatory Care to Underserved Populations in Tecate, Mexico

(9-188) Association Between Adherence to Monthly IM Naltrexone and Clinical Outcomes in a Pharmacist-Led Addiction Medicine Clinic for Alcohol Use Disorder

(9-189) Belatacept with Reduced Tacrolimus in Lung Transplant Recipients

(9-190) Preventing Infections in Patients Receiving T-Cell Redirection Therapies: Experience from a Comprehensive Cancer Center

(9-191) Cystatin C vs Cockcroft-Gault: A Retrospective Evaluation of Renal Function Estimation and Its Impact on Medication Dosing and Outcomes

(9-193) A Retrospective Analysis of Semaglutide vs Liraglutide in the Incidence of Hepatocellular Carcinoma

(9-194) Impact of Targeted Patient Outreach on Hormonal Contraceptive Furnishing Rates in the Community Pharmacy Setting

(9-195) Crystal Clear Guideline on the Recognition and Management of Methamphetamine-Induced Psychosis

(9-196) Pharmacist-Integrated Street Medicine and SVR12 Achievement in Unhoused Individuals with Hepatitis C

(9-197) Developing and Evaluating Clinical Documentation Tool in Transition of Care Setting

(9-198) Pharmacists and Perimenopause: Bridging Knowledge Gaps in OTC Care for Women’s Midlife Health

(9-199) Implementation of Pharmacy-Developed Education and a Clinical Decision Support Tool on the Rate of Rabies Post-Exposure Prophylaxis Administration in a Community Hospital Emergency Department

(9-200) Evaluating the Effect of a Pharmacist-led Education on Referrals for Benzodiazepine Tapers and Deprescribing in an Ambulatory Care Setting

(9-201) Assessing Compliance Post-Implementation of Vaccine for Children Program utilizing Hepatitis B Vaccine in a Community Health System

(9-202) Ensuring Safe and Effective Medication Use in Thoracoomphalopagus Conjoined Twins: A Structured Approach to Clinical and Implementation Decision-Making

(9-203) Management of Refractory Agitation in a Neonate: A Case Report

(9-204) Management of severe hypernatremia in a 7-year-old pediatric patient with hypovolemic shock

(9-205) The evaluation of medicated vs non-medicated intubations in a neonatal intensive care unit to create an intubation medication order set

(9-206) Development and Implementation of a Pediatric Pharmacist Emergency Response Certification (pPERC) in a Children’s Hospital

(9-207) Reevaluation of Criteria to Discontinue Neonatal Early Onset Sepsis Antibiotics at 24 Hours

(9-208) Management of Blunt Cerebrovascular Injury in Pediatrics

(9-209) Development of Rapid Onset Heparin Induced Thrombocytopenia in a Critically Ill Pediatric Patient

(9-210) Medication Use Evaluation for Droperidol Use in a Hospital Setting

(9-211) Assessing Efficacy, Safety, and Prescribing of Naloxegol in an Inpatient Setting

(9-212) Improving Discharge Medication Delivery Through a Meds-to-Beds Program, a Retrospective Review

(9-213) Improving Antifungal Stewardship: A Medication Use Evalulation of Isavuconazonium in Hematology, Oncology, and Solid Organ Transplant Care

(9-214) Evaluation of Inhaled Tobramycin Use in the Neonatal Intensive Care Unit

(9-215) Evaluation of a Pharmacist-Driven Emergency Department Culture Call Back Program: A Retrospective Review

(9-216) Colorado Health Professional Students’ Awareness and Perceptions of Community Pharmacist-Provided Clinical Services

(9-217) Evaluation of a Liberalized Nicardipine Titration Protocol in Acute Stroke in Two Trauma Centers

(9-218) Evaluation of Angiotensin II Use and Adherence to Current Institutional Criteria

(9-219) Evaluation of Albumin Usage and Compliance with Clinical Use Criteria After Implementation of an Albumin Order Panel

(9-220) Evaluation of Inpatient Intravenous Levothyroxine Utilization at UCHealth

(9-221) Dose of Norepinephrine at the Time of Vasopressin Initiation in Management of Septic Shock: A Medication Use Evaluation

(9-222) Impact of Crotalidae Polyvalent Immune Fab vs Crotalidae Immune F(ab)2 Administration in Rattlesnake Envenomation on Health-System Cost and Patient Outcomes in Southern Colorado

(9-223) Culture Takes Time, Infection Does not: A Case of Delayed Treatment for K.pneumoniae ESBL

(9-224) Improving Utilization of Grant-Funded Naloxone at UCHealth Poudre Valley Hospital

(9-225) Intravenous Iron Prescribing for Postpartum Anemia

(9-226) Evaluation of a Nebulizer Frequency Adjustment Protocol Across a Large Academic Health System

(9-227) From Burnout to Balance: Assessing Preceptor Well-Being and Opportunities for Improvement

(9-228) Creation of Standard Criteria for the Do Not Auto-Verify Medication List Within the Emergency Departments of a Large Health System

(9-229) Impact of an EHR-Embedded Urine-Testing Algorithm on Diagnostic Stewardship and Antibiotic Use for Asymptomatic Bacteriuria: A Multi-Site Interrupted Time-Series Study

(9-230) Evaluating Prescribing Practices and Clinical Outcomes of Sodium Zirconium Cyclosilicate for Acute Hyperkalemia Management at a Multi-Hospital Health System

(9-231) Efficacy and Safety Evaluation of a Pharmacist- Driven Diuretic Protocol

(9-232) Clinical Impact on the Timing of Anticoagulation Switch in Patients with Documented Heparin-Induced Thrombocytopenia

(9-233) Agonizing truths: the Alpha-2 story in overdose cases

(9-234) Role of Pharmacist-Driven Home Blood Pressure Monitoring and Medication Education in Preventing Post-Partum Readmission of Women with Hypertensive Disorders of Pregnancy

(9-235) Impact of Pharmacist-Led Titration of GLP-1 and GIP/GLP-1 Receptor Agonist: Effects on Weight Loss in Endocrinology and Cardiometabolic Clinics

(9-236) POUNCE Protocol: Pharmacist-Led Optimization of PCSK9 Inhibitor Utilization Through Sample Distribution and New-Start Counseling with Education

(9-237) Achieving therapeutic IV heparin infusion using an alternative 15 units/kg/hour initial infusion protocol

(9-238) Evaluation of a Clinical Decision Support Tool on the Assessment and Treatment of Community-acquired Pneumonia

(9-239) Development and Implementation of a Standardized Inpatient Pharmacy Technician Training Program

(9-240) Evaluation of clinical decision support use for needlestick post-exposure medications given in the emergency department: a retrospective medication use evaluation

(9-241) Evaluation of Therapeutic Duplications in Medications Prescribed as Needed for Pain

(9-242) Evaluating Medication-Related Issues Identified Through Post-Discharge Phone Calls: A Medication Use Evaluation

(9-243) Clinical Impact of Targeting a Narrow Vancomycin AUC Range of 350–500 mg·h/L Without Adjustment for MIC in Patients with Methicillin-Resistant Staphylococcus aureus Infections

(9-244) Evaluation of Intravenous Unfractionated Heparin Dosing in Obese Patients Using Anti-Xa Levels; A Multicenter, Retrospective Cohort Study

(9-245) Evaluating Post-Operative Pain Management Prescribing Patterns for Abdominal Surgeries

(9-246) Assessment of the management of patients in primary care setting with stage 2 hypertension, based on guidelines.

(9-247) Evaluating the Impact of a Pharmacist-Led Diabetes Optimization in Transitions of Care (DOT-TOC) Program on Post-Discharge Outcomes

(9-248) Evaluation of Unintended Antibiotic Therapy Interruptions Following Implementation of EHR-Mandated Duration Fields

(9-249) Efficacy of narcotic use for terminal withdrawal of mechanical ventilation at end-of-life

(9-250) Evaluation of Therapeutic Rivaroxaban Use in Peripheral Artery Disease Patients Following Lower Extremity Revascularization

(9-251) A Quality Improvement Project Utilizing Patient-Centered Surveys to Assess Medication Nonadherence and Access Barriers in Underserved Populations

(9-252) Deprescribing of Multiple Anticholinergics in Patients Over 65 Years Old in the Primary Care Setting

(9-253) Impact of Pharmacist Intervention on Chronic Kidney Disease Screening and Optimization of Guideline Directed Medical Therapy in Adult Patients with Type 2 Diabetes

(9-254) Impact of Pharmacist Led Identification and Reconciliation of High-Risk and Potentially Inappropriate Medications (PIMs) in Elderly Patients

(9-255) Expansion and Re-Implementation of a Pharmacist-Driven Renal-Dose Adjustment Protocol

(9-256) Implementation of the Pharmacy Education Software MyDispense to Improve Pharmacist Training Across Different Oncology Treatment Settings

(9-257) Assessment of Vasopressor Utilization in Critically Ill and Code Patients: A Retrospective Review

(9-258) Safety of Cefazolin Versus Oxacillin for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Retrospective Cohort Study

(9-259) On Schedule, In Control: Evaluation of PRN IV Opioid Pain Reassessment in Compliance with Joint Commission Standards

(9-260) Impact of Dexmedetomidine Use in Stepdown Units on Length of Stay Compared to Patients Receiving Dexmedetomidine in the Intensive Care Unit

(9-261) Comparing Provider-Driven and Pharmacist-Driven Warfarin Dosing Protocols in the Inpatient Setting Across a Health System

(9-262) Evaluating the use of dornase alfa (Pulmozyme®) off-label use in pediatric and adult populations across Yale New Haven Health System

(9-263) Acute Care Clinical Pharmacist Shift Optimization

(9-264) Evaluation of Discharge Medication Destination in Multi-Visit Patients in a Five Hospital Health-System

(9-265) Evaluation of Vancomycin AUC Protocol at a Large Academic Medical Center

(9-266) Evaluation of Implementation of a Pharmacist Alert in the Electronic Medical Record for INR Change >0.5 in 24 Hours for Patients Receiving Warfarin

(9-267) Evaluation of Rifaximin Utilization and Clinical Pathway Adherence for Hepatic Encephalopathy Management

(9-268) Evaluating Long-Acting Injectable Antipsychotic Electronic Health Record Care Signature Pathway Use in Adult Inpatients

(9-269) Analysis of Hypercalcemia Management Across a Standardized Care Pathway: Prescribing Patterns and Denosumab Utilization Review

(9-270) Assessment of Continuous Intravenous Lidocaine for Acute Pain in Adults with Sickle Cell Disease

(9-271) Evaluation of AI Generated HCAPHS Data for Pharmacy Enhancement of Patient Experience in a Large Academic Health System

(9-272) Evaluation of Medication-Related Problems Identified During Discharge Medication Reconciliation and Transitions of Care in Multi-Visit Patients

(9-273) Evaluating the Appropriateness of Overnight Medication Administration to Improve Patient Satisfaction

(9-274) Evaluating the Impact of Transitioning from Cockcroft-Gault Equation to Chronic Kidney Disease Epidemiology Collaboration for Renal Dose Adjustment of Medications at a Five-Hospital Health System

(9-275) Evaluation of Nicardipine Use in the Emergency Department: Identifying Opportunity for Alternative Therapies

(9-276) Therapeutic Duplications of PRN Constipation Medications

(9-277) Evaluation of Prescribing Patterns and Utilization of the “Ambulatory Hypertension” Care Signature Pathway

(9-278) Evaluation of Care Pathway Use for Acute Gastrointestinal Bleeding in the Emergency Department

(9-279) Assessing Appropriate Uses of Methylene Blue as a Diagnostic Dye in the Perioperative Setting

(9-280) Risk Factors for Inpatient Hypoglycemia: An Institution-Specific Analysis

(9-281) Evaluation of Prescribing Patterns and Utilization of the Hyperlipidemia Care Signature Pathway

(9-282) Evaluation of Prescribing Patterns and Utilization of the “Overactive bladder and Urge/Stress incontinence for Women” Care Signature Pathway

(9-283) Evaluation of Prescribing Patterns and Utilization of the Adult Ambulatory Uncomplicated Urinary Tract Infection (UTI) Care Signature Pathway.

(9-284) Assessing an Updated Alcohol Withdrawal Protocol at a Community Health System: A Comparison of Phenobarbital to Benzodiazepines

(9-285) Assessing the Acceptance of Medication Recommendations Made by Pharmacists to Licensed Practitioners and the Impact on Polypharmacy Management

(9-286) Pneumonia Risk Associated with Continuing Proton Pump Inhibitors for Stress Ulcer Prophylaxis Beyond the Intensive Care Unit Stay

(9-287) Utilization of Business Intelligence Software to Conduct a Therapeutic Class Review of Solid Organ Transplant Medications

(9-288) Leveraging Business Intelligence Software for a Hematopoietic Agent Therapeutic Class Review

(9-289) Evaluation of Pantoprazole Prescribing Practices for Stress Ulcer Prophylaxis with Indication Requirement Implementation

(9-290) Review of Clinical Practice Change: Excluding Chlorhexidine from the Ventilator Care Bundle in the Intensive Care Unit

(9-291) Micafungin Utilization and the Impact of Criteria for Use

(9-292) Levetiracetam Dosing Strategies for Seizure Prophylaxis in the Neurosurgical Intensive Care Unit

(9-293) Comparison of stress ulcer prophylaxis in mechanically ventilated patients

(9-294) Facilitating Length of Stay Reduction by Optimizing Anticoagulation Bridging Through Pharmacy-Led Transitions of Care Clinic

(9-295) Impact of Time to Positive Blood Culture and Time to Appropriate Antimicrobial Therapy on Mortality in Critically Ill Patients with Bacteremia

(9-296) Evaluation of Initial Dose of Nitroglycerin for Acute Heart Failure Exacerbation

(9-297) Impact of Oral Naloxone on Analgesia in Critically Ill Patients Receiving Opioids for Constipation

(9-298) Impact of Anticoagulation Strategies on Thrombotic Events in Patients with Durable Left Ventricular Assist Devices

(9-299) Sedation Practices and RASS Goals in Targeted Temperature Management at 36°C and Their Impact on Time to Neurological Baseline

(9-300) Evaluation of Serum Phosphate Levels in Patients Receiving Continuous Renal Replacement Therapy in an Intensive Care Unit

(9-301) Evaluating the Effectiveness of Pharmacist-Led Medication Reconciliation at Discharge in the Emergency Department: Impact on Readmissions and Drug-Related Errors

(9-302) Evaluation of periprocedural antibiotic practices in high-risk patients undergoing cardiac implantable electronic device placement

(9-303) Comparative Safety of Inpatient versus Outpatient Step-Up Dosing for Bispecific T-Cell Engagers in Multiple Myeloma

(9-304) Chronic Opioid Use Post-Surgical Exposure in Opiate Naive Patients

(9-305) Comparison of Tenecteplase versus Alteplase for Pulmonary Embolism in Cardiac Arrest

(9-306) Intravenous Versus Subcutaneous Insulin Administration: Evaluation of Blood Glucose Control in the Critical Care Setting

(9-307) Evaluation of PRECISE-DAPT Score with Post-Discharge Gastrointestinal Bleeding (GIB) in Conary Artery Bypass Grafting (CABG) Patients Prescribed Dual Antiplatelet Therapy (DAPT)

(9-308) Implementation of a Criteria for Use for Custom Parenteral Nutrition: An Evaluation of Clinical Outcome and Cost Impacts

(9-309) Evaluating Methylene Blue Use in Patients with Shock at a Tertiary Care Center

(9-310) From ICU to the Floors: Evaluating Midodrine Prescribing Practices and Patient Outcomes

(9-311) Impact of Clinical Pharmacists on Glycemic Control in Primary Care Patients with Diabetes

(9-312) Impact of Pharmacist and Care Management Nurse Collaboration on Social Determinants of Health, Fiscal Outcomes, and Quality Improvement

(9-313) Evaluation of a Pharmacist-Driven Discharge Medication Reconciliation Service

(9-314) Comparison of Cisatracurium and Atracurium in Acute Respiratory Distress Syndrome: A Retrospective Observational Study

(9-315) Evaluation of Cardiac Outcomes for Levothyroxine Continuous Infusion in Brain Dead Organ Donors

(9-316) Impact of Pharmacist Intervention on Emergency Department Sepsis Order Set and Sepsis Bundle Compliance

(9-317) A Study on the Safety and Efficacy of Sodium Zirconium Cyclosilicate versus Sodium Polystyrene Sulfonate in Hyperkalemia Management

(9-318) Development of a Multi-Disciplinary Medication Reconciliation Program within a Pediatric Health System

(9-319) Intravenous to oral antibiotic step-down at 72 hours in uncomplicated gram-negative bacteremia

(9-320) Utilization Patterns of Cyclobenzaprine and Orphenadrine in Patients Aged 65 and Older

(9-321) Hydrocortisone Medication Use Evaluation for Refractory Septic Shock at Ascension St. Vincent's Facilities

(9-322) Inpatient Management of Opioid-Induced Constipation in Chronic Opioid Users

(9-323) Assessment of appropriate dosing strategies for sugammadex and rocuronium in obese patients during the perioperative period

(9-324) Impact of Skeletal Muscle Relaxants on Opioid Utilization and Safety Outcomes in Perioperative Surgical Patients

(9-325) Medication Use Evaluation of Treatment, Prophylaxis, and Suppression for Clostridioides difficile Infection at a Community Hospital

(9-326) A Retrospective Review Evaluating the 2024 Kidney Disease: Improving Global Outcomes (KDIGO) eGFR Equation Versus the Cockcroft-Gault Equation in Patients at a Community Hospital

(9-327) Retrospective, Multi-center Evaluation of Reflex Fosfomycin Susceptibility Testing on Oral Fosfomycin Prescribing

(9-328) Restoring Control: A Medication Use Evaluation of Vibegron in the Treatment of Overactive Bladder

(9-329) Impact of Meds2Beds Pharmacy Dispensing on 30-Day Readmissions at a Large Health System

(9-330) Evaluating the Impact of the Medicare Prescription Payment Plan (M3P) on Medication Adherence in an Outpatient Health-System Pharmacy Setting

(9-331) Beyond Statins: A Medication Use Evaluation of Bempedoic Acid in Hyperlipidemia Management

(9-332) Evaluation of Barcode Enabled Medication Delivery Tracking Software: Impact on Workflow Efficiency and Cost Reduction

(9-333) Comparison of Clinical Outcomes of High-dose versus Low-dose Fluconazole Prophylaxis in a Neonatal Intensive Care Unit

(9-334) Evaluating Spontaneous Awakening Trial and Spontaneous Breathing Trial Compliance in Mechanically Ventilated Intensive Care Unit Patients at a Community Based Hospital

(9-335) Optimizing Vancomycin Dosing: A Comparative Analysis of Two-Level vs. Single-Level AUC Strategies in a Community Health System

(9-336) Evaluating weight-appropriate dosing in pediatric patients in a community-based health care system emergency departments

(9-337) Assessment of Anterior Epistaxis Management in an Adult Emergency Department

(9-338) Evaluation of von Willebrand Factor Formulations Use in Acute Care Setting Across a Health-System

(9-339) Evaluation of Albumin, Midodrine, and Octreotide Use in the Management of Hepatorenal Syndrome

(9-340) Evaluating Patient Selection for Inotropic Agents in Hospitalized Patients

(9-341) Evaluation of Continuous Infusion Ketamine in Critically Ill Adult Hospitalized Patients

(9-342) Appropriate Use of Calcium-Lowering Agents in Malignant Hypercalcemia and Its Impact on Time to Discharge

(9-343) Predictors of a Successful Transition from Intravenous to Subcutaneous Insulin Post Open-Heart Surgery in Diabetic Patients

(9-344) Impact of Obesity on Time to Therapeutic Anticoagulation in Hospitalized Adults Receiving Heparin Infusions

(9-345) Clinical Utility of Methicillin-resistant Staphylococcus aureus (MRSA) Nasal Swab Polymerase Chain Reaction (PCR) for Diabetic Foot Infections, Osteomyelitis, and Joint Infections in Adult Patients.

(9-346) Comparing Olanzapine vs Haloperidol for Acute Agitation in the Pediatric Emergency Department

(9-347) Optimizing Biosimilar Utilization in Infusion Centers: Advancing Supply Chain Efficiency, Cost Containment, and Clinical Alignment Across BayCare

(9-348) Effectiveness of Intravenous Valproic Acid as Adjunctive Therapy for Acute Migraine Treatment in the Emergency Department: A Comparative Effectiveness Study

(9-349) Impact of Prophylactic Gentamycin irrigation on CAUTI Rates in Trauma Patients

(9-350) Multi-Site, Retrospective Evaluation of an Education Campaign and Order Set Update to Support Diagnostic Stewardship for Pneumococcal Urinary Antigen Testing

(9-351) The Impact of Dexmedetomidine versus Propofol on Delirium in Mechanically Ventilated Geriatric Patients

(9-352) Comparative effectiveness and safety of tolvaptan vs. 3% hypertonic saline (HTS) in asymptomatic euvolemic or hypervolemic hyponatremia: A cohort analysis

(9-353) Operating Room Optimization for 340B Maximization & WAC Reduction

(9-354) Impact of Anticoagulant Use on Thromboelastography (TEG) Parameters in Patients with Traumatic Brain Injury at Two Trauma Centers

(9-355) Effects of DDAVP verses Platelets versus Neither in Patients on Antiplatelet Therapy Presenting with a Traumatic Brain Injury and Intracranial Hemorrhage

(9-356) Implementation of Pharmacist driven Proton Pump Inhibitor (PPI) Discontinuation Policy for patients transferred out of Intensive Care Units.

(9-357) Propofol Washout in the Pediatric Intensive Care Unit

(9-358) Time to resolution of Diabetic Ketoacidosis (DKA) in Intensive Care versus Medical-Surgical Units: a retrospective cohort study

(9-359) Utilization of Order Sets in the Management of Hyperkalemia: A Retrospective Chart Review with a Focus on Safety

(9-360) Comparative Effectiveness of Intravenous Beta Blockers versus Vasodilators and Calcium Channel Blockers in the Initial Management of Type A Aortic Dissection

(9-361) Comparison of Metronidazole BID vs TID Dosing in the Management of Anaerobic Infections in Hospitalized Adults: A Retrospective Cohort Study

(9-362) Evaluating Efficacy and Patient Outcomes of a Hospital Care At Home Program.

(9-363) Impact of Pharmacist-Led Post-Discharge Medication Reconciliation for High-Risk Patients

(9-364) Increasing Immunization Rates Through Vaccine Co-Administration

(9-365) Evaluating the Impact of a Medication Synchronization Program on Refill Adherence of Chronic Medications.

(9-366) Evidence-Based Pharmacist-Led Strategies to Improve Antiretroviral Therapy (ART) Adherence in Adults Living With HIV

(9-368) Pharmacist-Led Interventions to Improve Antidepressant Adherence

(9-369) Reducing Medication Errors at Discharge: Impact of Pharmacist-Led Reconciliation

(9-370) Improving Utilization of Pharmacist Therapeutic Substitution Protocols to Reduce Provider Task Burden at a Federally Qualified Health Center

(9-371) Impact of Pharmacist-Led Medication Therapy Management and Pillbox Interventions on Adherence in Polypharmacy Patients at a Federally Qualified Health Center

(9-372) Investigation of Carbapenem vs. Noncarbapenem Beta-Lactam Therapy in E. coli and K. pneumoniae Ceftriaxone Non-susceptible Intra-abdominal Infections

(9-373) Evaluation of Emergency Department Culture Callback Processes for Antimicrobial Stewardship Opportunities

(9-374) Impact of Emergency Department Pharmacists on Timely Sepsis Bundle Completion and Clinical Outcomes

(9-375) A Comparison of Lorazepam and Phenobarbital Efficacy for Alcohol Withdrawal Symptoms Managment in HCA Aventura Hospital

(9-376) Evaluation of weight-based versus standard diltiazem dosing in patients with atrial fibrillation in the emergency department

(9-377) Efficacy of Intravenous Magnesium Sulfate in Asthma Exacerbations: Determining the Optimal Dose

(9-378) Evaluating the Appropriateness of Empiric Ceftriaxone Therapy for Suspected Sepsis in the Emergency Department

(9-379) Assessing the Utilization and Outcomes of Calcitonin Therapy: A Medication Use Evaluation

(9-380) Rifaximin Inpatient Utilization for Hepatic Encephalopathy Medication Use Evaluation (MUE)

(9-381) Direct Oral Anticoagulants and Potential Inconsistencies with Recommended Dosing in Atrial Fibrillation

(9-382) Improving Timely Administration of Nimodipine in Aneurysmal Subarachnoid Hemorrhage: A Quality Improvement Initiative

(9-383) Impact of Pharmacist-Led Discharge Interventions on 30-day Hospital Readmissions

(9-384) Clot Busters Compared: Tenecteplase Versus Alteplase Safety and Efficacy in Acute Ischemic Stroke

(9-385) Comparison of Sedation Strategies for Intubated Patients in the ICU

(9-386) Comparing VTE Prophylaxis with Enoxaparin in Low Body Weight Patients with Renal Dysfunction vs Normal Renal Function

(9-387) Evaluation of Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Hospitalized Adults: A Pharmacist-Driven Retrospective Analysis

(9-388) Pharmacist-Led Anticoagulation Reconciliation at Hospital Discharge

(9-389) Impact of Education on Discharge Antimicrobial Prescribing for Urinary Tract Infections in the Emergency Department

(9-390) Impact of Rapid Blood Culture Identification for Gram-Positive Bacteremia

(9-391) Evaluation of Dosing Limits on Weight Based Unfractionated Heparin Protocols

(9-392) Evaluation of a Pharmacist-Driven Vancomycin-to-Linezolid Therapeutic Interchange Protocol

(9-393) Cannabis use in Trauma Patients and its Effects on Pain Management

(9-394) Evaluating the Impact of a Pharmacist-driven Protocol in an Inpatient Hospital: Auto-substitution from Piperacillin-tazobactam and Vancomycin to Cefepime and Vancomycin Empiric Therapy

(9-395) Administration of Midodrine, Droxidopa, or the Combination of Droxidopa and Midodrine for Discontinuing Hemodynamic-Stabilizing Pharmacotherapy: a Comparison of Oral Vasopressors in Critically Ill Patients

(9-396) Take-home naloxone kits for Emergency Department and Obstetric patients

(9-397) Minimizing Sleep Disruptions in Hospitalized Adults Receiving Sleep Aids: A Pre-Post Implementation Study

(9-398) Evaluation of pharmacy-led albumin stewardship in the hospital setting

(9-400) Two-Bag Versus Three-Bag N-Acetylcysteine Regimen for Pediatric Acetaminophen Overdose

(9-401) Trauma Venous Thromboembolism (VTE) Prophylaxis on Discharge

(9-402) Factor Replacement Product Use in the Emergency Department

(9-403) Evaluation of Prescribing Trends for Heart Failure Patients in the Ambulatory Setting

(9-404) Evaluation of Fidaxomicin Prescribing in the Treatment of Clostridioides Difficile Infection

(9-405) Pharmacologic Management of NSTEMI and Type II MI in the ICU

(9-406) Impact of a Pharmacist-Led Quality Improvement Initiative on the Safe Use of Intravenous 3% Hypertonic Saline in Adults

(9-407) Assessing the Use of Inpatient Intravenous Immune Globulin within a Community Health System

(9-408) Impact of Nephrotoxic Medication Exposure on Acute Kidney Injury Rates in Pediatric and Neonatal Patients

(9-409) Evaluation of a Weight-Based Basal Insulin Dose for Transitioning off Insulin Infusion in Diabetic Ketoacidosis

(9-410) Evaluation of the Treatment of Community Acquired Intra-Abdominal Infections

(9-411) Impact of Electronic Antibiotic Timeout Practice Alerts on Prescribing at a Community Health System

(9-412) Door to Reversal Time for Patients with Intracranial Hemorrhage on Oral Anticoagulants in the Adult Emergency Department

(9-413) Medication Use Evaluation of Diltiazem: Assessing Appropriateness and Ordering Practices at Manatee Memorial Hospital

(9-414) Meropenem Utilization and Outcomes in Hospitalized Patients

(9-415) Impact of Intravenous Diazepam versus Intravenous Lorazepam on Intubation Rates for Patients Experiencing Alcohol Withdrawal Syndrome

(9-416) Intravenous Push Versus Intravenous Piggyback Cefazolin for the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia

(9-417) Evaluation of hydration protocols and electrolyte supplementation in patients receiving cisplatin

(9-418) Retrospective Evaluation of Epinephrine 0.3 mg versus 0.5 mg in Anaphylaxis and Angioedema: Patterns of Repeat Dosing and Adverse Events

(9-419) Incidence of Preeclampsia Associated with the Administration of Methylergonovine for the Management of Postpartum Hemorrhage

(9-420) Comparing the Effectiveness of Sodium Polystyrene Sulfonate and Sodium Zirconium Cyclosilicate for the Treatment of Acute Hyperkalemia in Hospitalized Patients

(9-421) Assessing the Effectiveness of a Pharmacist-Based Call Back Program in the Emergency Room of a Community Hospital

(9-422) An evaluation of the appropriateness of Recombinant Coagulation Factor VII (rFVII) utilization across a multi-hospital health system

(9-423) Enteral vs Continuous Infusion Diltiazem Maintenance Therapy for Patients in Atrial Fibrillation with Rapid Ventricular Response

(9-424) Safety and Efficacy of Mixed Insulin in Hospitalized Patients

(9-425) Stewardship-Focused Evaluation of Daptomycin Prescribing Practices in a Community Healthcare System

(9-426) High Reliability Auditing: Pharmacy Technician Automated Dispensing Cabinet Workflow Compliance

(9-427) Incidence of Acute Rejections in Adult Orthotopic Heart Transplant Recipients With or Without Basiliximab as Induction Therapy

(9-428) LAI Utilization and Treatment Response Across Diverse Populations

(9-429) Breaking the Pain Barrier: Impact of a Revised PCA Order Set in Sickle Cell Crisis Care

(9-430) Evaluation of a Dynamic System List Tool to Optimize Patient Care Prioritization

(9-431) A Second Line of Defense: Fomepizole in Acetaminophen Toxicity

(9-432) Optimizing the Administration of Iron Dextran

(9-433) Four-Factor Prothrombin Concentrate Use in Heart Transplant: An Evaluation of Post-operative Thrombotic Complications

(9-434) An Evaluation of Once Versus Twice Daily Enoxaparin for VTE Prophylaxis in Trauma ICU Patients

(9-435) Evaluation of Bleeding Risk Prediction by Comparing DOAC and HAS-BLED Scores in Patients on Oral Anticoagulation for Atrial Fibrillation

(9-436) Retrospective Evaluation of Criteria-Based Isavuconazole Utilization for the Prevention and Treatment of Invasive Fungal Infections

(9-437) Use of Bivalirudin Versus Argatroban Drip in Continuous Renal Replacement Therapy Patients

(9-438) Adenosine versus Diltiazem for the Management of Supraventricular Tachycardia in the Emergency Department

(9-439) Difference in Opioid Use Expressed in Morphine Milligram Equivalents Between Lateral Subvastus and Medial Parapatellar Approaches for Total Knee Arthroplasty

(9-440) Impact of Rapid Blood Culture Identification (BCID2) on Time Targeted Antifungal Therapy in Patients with Fungemia: A Pre/Post Retrospective Evaluation

(9-441) Penicillin Allergy De-Labeling as a Driver of Antimicrobial Stewardship: Safety, Efficacy, and Impact on Patient Outcomes

(9-442) Retrospective Analysis of Remifentanil with Reduced Propofol Doses Versus Etomidate-Monotherapy on Seizure Quality in Electroconvulsive Therapy

(9-443) Evaluating the Use of Biologics in the Inpatient Setting at a Free-Standing Children’s Hospital

(9-444) Baseline Assessment of Penicillin Allergy Labels and Estimated Impact of a Penicillin Allergy De-Labeling Pathway on Antibiotic Utilization in Pediatric Infections

(9-445) Evaluating the Efficacy of Enteral Naloxone in Intensive Care Unit Pediatric Patients with Opioid-Induced Constipation: Secondary Analysis to Study Health Outcomes in Pediatric Pharmacy

(9-446) Comparative Incidence of Sinusoidal Obstruction Syndrome/Veno-occlusive Disease in Pediatric Acute Leukemia Patients Treated With Gemtuzumab or Inotuzumab Stratified by Utilization of Ursodiol Prophylaxis

(9-447) Coping with Residency Stress: Prevalence of Medication Use Among Pharmacy Residents

(9-448) Metabolic Outcomes Associated with Antipsychotics, Mood Stabilizers, or Their Combination in an Inpatient Psychiatric Hospital: A Retrospective Study

(9-449) Evaluating Patient Adherence and Economic Outcomes of a University-Affiliated Pharmacy Call Center Intervention

(9-450) Seizure Following Inadvertent Intravenous Administration of Doxycycline and Bupivacaine Sclerotherapy: A Case Report

(9-451) Incidence of Angioedema in Tenecteplase versus Alteplase for Treatment of Ischemic Stroke

(9-452) Linezolid-Eligible MRSA Pneumonia Patients Treated with Vancomycin: A Retrospective Cost-Minimization Analysis

(9-453) Daily and Cumulative Opioid Use in Intensive Care Unit Patients Receiving Propofol Versus Dexmedetomidine: A Retrospective Cohort Study

(9-454) LAI Antipsychotic Discharge Outcomes

(9-455) Pharmacist Driven Stress Ulcer Prophylaxis Deprescribing

(9-456) Evaluation of Revised Hyperkalemia Order Set Implementation on Incidence of Insulin Administration and Adverse Glycemic Effects within a Community Healthcare System

(9-457) Evaluation of a Delirium Order Set on Antipsychotic and Benzodiazepine Administration in Elderly Patients with Acute Hip Fracture

(9-458) Evaluation of a Pharmacy-driven Antibiotic Surgical Prophylaxis Protocol for Patients with a Penicillin Allergy

(9-459) Evaluating the Impact of an Antibiotic Prophylaxis Guideline on Antibiotic Duration in Patients with Traumatic Facial Fractures

(9-460) Evaluating Urine pH as an Indicator of Resistance to First-line Therapy Prescribed in Patients Presenting with Urinary Tract Infections

(9-461) Composite Bleeding Outcomes with Oral P2Y12 Inhibitors and Aspirin Post Percutaneous Coronary Intervention

(9-462) Antibiotic Stewardship for Asymptomatic Bacteriuria Within the Emergency Department of a Community Healthcare System

(9-463) Impact of a Non-Aminoglycoside-Based Regimen for Open Fracture Prophylaxis in Trauma Patients

(9-464) Evaluating Opioid Prescribing Patterns for Opioid-Naïve Patients in the Hospital Setting

(9-465) Water Triggers Seizures: Psychotropic Management in Psychogenic Polydipsia and Hyponatremia

(9-466) Retrospective Multicenter Evaluation of Oral Step-down versus Intravenous Carbapenem Treatment of Extended-Spectrum Beta-lactamase Producing Escherichia coli Urinary Tract Infections

(9-467) Impact of Pharmacotherapy on the Risk of Necrotizing Enterocolitis in a Level III Neonatal Intensive Care Unit: A Single-Center Cohort Study

(9-468) Impact of single high dose aminoglycosides versus standard of care in extended-spectrum beta-lactamase Enterobacterales urinary tract infections

(9-469) Evaluation of Low-Dose 4-Factor Prothrombin Complex Concentrate for Reversal of Intracerebral Hemorrhages in Patients taking Apixaban or Rivaroxaban.

(9-470) A Retrospective Evaluation of Lactated Ringer’s versus Normal Saline for Initial Fluid Resuscitation in Adults with Diabetic Ketoacidosis

(9-471) Strategic Evaluation of Meds2Beds: Implications for Contract Renewal and Enterprise Growth at BayCare

(9-472) Assessing Hypersensitivity Frequency and Severity in Patients Administered Calaspargase compared to Pegaspargase for Acute Lymphoblastic Leukemia

(9-473) Evaluating Opioid and Sedation Conversion Strategies and Weaning Durations in Critically Ill Pediatric Patients

(9-474) Decentralized Emergency Medicine Pharmacist Impact on Time to 4-Factor Prothrombin Complex Concentrate Administration

(9-475) Early vs Guideline Directed Initiation of Antifungals in Febrile Neutropenia

(9-476) Short-Term Versus Long-Term Carbapenem Therapy for Complicated Urinary Tract Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacterales

(9-477) Impact of Technology-Integrated Sterile Compounding Hoods on Efficiency and Safety in Practice

(9-478) Evaluation of Ketamine Versus Etomidate for Rapid Sequence Intubation in Critically Ill Patients

(9-479) Comparison of daptomycin versus vancomycin treatment outcomes in uncomplicated methicillin resistant Staphylococcus aureus bacteremia

(9-480) Leveraging Telehealth Interventions for Early Adherence Support in Heart Failure Optimization

(9-481) Efficacy of Olanzapine in the Management of Cannabinoid Hyperemesis Syndrome in the Emergency Department

(9-482) Impact of Pharmacist Intervention on Blood Pressure Management Following Emergency Department Encounters

(9-483) Phenobarbital versus Benzodiazepines for Alcohol-Withdrawal Management in the Emergency Department

(9-484) Intravenous Ondansetron versus Palonosetron for Prevention of Delayed Chemotherapy Induced Nausea and Vomiting for Moderately Emetogenic Chemotherapy Regimens

(9-485) Evaluation of Clinical Pharmacist Involvement in Reducing Anticholinergic Cognitive Burden: A Medication Review Initiative

(9-486) Expanding the Role of Independent Pharmacies: Initiating a Chronic Care Management Program

(9-487) Heparin Monitoring Using Anti-Xa versus aPTT: A Retrospective Chart Review of Time to Therapeutic Anticoagulation

(9-488) The Cost of Omission: Evaluating Glycemic Outcomes of Withheld Insulin Administration

(9-490) Evaluation of Medication Order Auto-Verification System in the Emergency Department at a Community Hospital: A Quality improvement Project

(9-491) Impact of Weight-Based Rocuronium Dosing Strategies in Obese Versus Non-Obese Patients Undergoing Rapid Sequence Intubation in the Emergency Department

(9-492) Evaluation of a Pharmacist-Led Intervention to Discontinue Stress Dose Hydrocortisone Therapy After Transfer from the Intensive Care Unit: A Retrospective Cohort Study

(9-493) Evaluating the Clinical Utility of Indium-111 White Blood Cell Scans in Antimicrobial Decision-Making: A Retrospective Cohort Analysis

(9-494) Evaluation of an Intravenous Fluids Conservation Protocol in Hospitalized Pediatric Patients During a Period of Shortage

(9-495) Investigating the Hepatic Effects of SMOFlipid vs Intralipid in Pediatric Patients

(9-496) Evaluating the Effect of a Methicillin-Resistant Staphylococcus aureus Decolonization Protocol on Colonization Rates in the Neonatal Intensive Care Unit.

(9-497) Pharmacist-Led Culture and Susceptibility Follow-Up Program in the Emergency Department: A Pilot Study

(9-498) DOAC Dashboards to Improve Inpatient Care: Pharmacy Resident Collaboration on Antithrombotic Stewardship

(10-001) Evaluation of Medication History Collection in a Community Hospital Prior to Implementation of a Pharmacy-Driven Program

(10-002) Evaluation of Medication Prescribing at Discharge for Patients with Heart Failure Before and After Implementation of Pharmacist Involvement

(10-003) Improving VTE Prophylaxis in Multiple Myeloma: An EHR-Based Approach Using IMPEDE and SAVED Risk Stratification Tools in an Outpatient Setting

(10-004) Comparative Outcomes of Oral Beta-Lactams Versus Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Step-Down Therapy in Enterobacterales Bacteremia Secondary to Urinary Tract Infections

(10-005) Safety and Efficacy of Antithrombin Administration at a Quaternary Pediatric Institution

(10-006) From Stabilization to Silencing: Assessing Adherence and Outcomes of Tafamidis and Vutrisiran in Patients with Cardiac Amyloidosis in a Rural Setting

(10-007) Impact of Amlodipine to Nifedipine Conversions by a Remote Pharmacy Hypertension Service

(10-008) Evaluation of lipid profiles in patients taking tumor necrosis factor alpha inhibitors for Inflammatory Bowel Disease

(10-009) Outcomes with Full Versus Reduced Dose Rivaroxaban and Apixaban After Initial Venous Thromboembolism Treatment

(10-010) Real World Conversion from NPH to Insulin Glargine-yfgn in an Outpatient Clinic Setting

(10-011) Incidence of Sodium Overcorrection with Acute Tolvaptan Use

(10-012) Effect of sepsis order set transition of empiric antipseudomonal agents on antimicrobial de-escalation

(10-013) Evaluation of Insulin Dosing in Hyperkalemia Protocol

(10-014) Comparison of Oral Vancomycin Dosing Strategies for Initial, Non-fulminant C. difficile Infection Treatment

(10-015) Evaluating Heparin Infusions and Resultant Monitoring Parameters

(10-016) Epoetin Alfa Administration in Intermittent Hemodialysis

(10-017) Evaluation of Inhaled Mucolytic Prescribing Practices within a Community Health System

(10-018) Evaluating the transition from IV to SC insulin when treating DKA at a tertiary care teaching hospital

(10-019) Factors Associated With Nocturnal Hypoglycemia In A Small Community Hospital

(10-020) Micafungin Treatment Failure in Obese Patients: Standard versus Body Mass Index-Adjusted Dosing Regimens

(10-021) Analgesic Dosed Ketamine Infusion for Pain Control of Trauma Patients in the Critical Care Setting

(10-022) Evaluation of Ketamine for Anhedonia in Advanced Heart Failure Patients at a Tertiary Medical Center

(10-023) Evaluation of Transitions from Intravenous Prostacyclin Therapy to Oral Selexipag or Treprostinil

(10-024) Evaluation of Perioperative Sugammadex Utilization at a Tertiary Care Center

(10-025) Incidence of Mechanical Ventilation in the Emergency Department among Patients with Acute Pulmonary Edema Utilizing High versus Low Dose Intravenous Nitroglycerin

(10-026) Retrospective data review of adherence rates, drug interactions, and perceived outcomes in patients prescribed resmetirom in a community-based specialty pharmacy.

(10-027) Implementation of a Pharmacist-Led Penicillin Allergy History Algorithm with the Direct Oral Amoxicillin Challenge in Hospitalized Patients

(10-028) Evaluating the Efficacy of Rifaximin Monotherapy versus Rifaximin Plus Lactulose for the Treatment of Recurrent Hepatic Encephalopathy in Hospitalized Patients with Cirrhosis

(10-029) Impact of a Pharmacist-Led Practice Change in Anti-Xa Monitoring on Bleeding Rates in Burn Injury Patients Receiving Enoxaparin for Venous Thromboembolism Prophylaxis

(10-030) Evaluation of Vitamin K Antagonist versus Direct Oral Anticoagulants in the Management of Left Ventricular Thrombus

(10-031) Assessing the Use of Temazepam in the Elderly

(10-032) Medication Use Evaluation: Assessing Appropriateness, Safety, and Efficacy of Eravacycline

(10-033) Medication Use Evaluation (MUE): Assessing the Use of Albumin in Acute Care Units

(10-034) Safety and Efficacy of Bivalirudin in Patients Receiving Extracorporeal Membrane Oxygenation

(10-035) Comparison of Hemoglobin A1C Reduction Using Continuous Versus Remote Blood Glucose Monitoring in Insulin Dependent Adults with Type 2 Diabetes: A Retrospective Cohort Study

(10-036) Improving Medication Adherence and Care-Gap Closure through Team-Based Multimodal Outreach

(10-037) Assessment of Pharmacist- Led Strep Test and Treat Services on Patient Outcomes and Satisfaction

(10-038) Enhancing Osteoporosis Management: An Emphasis on Bisphosphonate Optimization

(10-039) Evaluating Clinical Inertia in GLP-1 Receptor Agonist Initiation and Titration in a Federally Qualified Health Center

(10-040) Implementation of a Venous Thromboembolism (VTE) Prophylaxis Protocol in an Ambulatory Oncology Center

(10-041) Optimizing IV Acetaminophen Usage at a Community Hospital

(10-042) Evaluation of Tenecteplase for Pulmonary Embolism and Pulmonary Embolism-Associated Cardiac Arrest at a Community Hospital

(10-043) Evaluation of Emergency Department Urine Culture Management and Patient Outcomes

(10-044) Evaluation of Blood Glucose Management for Inpatients in a Community Health System

(10-045) Duplicate Antibiotic Coverage in Skin and Soft Tissue Infections, Including Assessment of Worsening Cellulitis Within a Community Health System

(10-046) Evaluation of Goal-Directed Medication Therapy in Heart Failure with Reduced Ejection Fraction

(10-047) Evaluation and Expansion of the Outpatient Pharmacy Therapeutic Substitution Policy Implemented by St Luke’s Health System

(10-048) Evaluation of Rapid Sequence Intubation and Post Intubation Analgosedation Practices in Adult Emergency Department Patients

(10-049) Evaluation of Psychiatric Medication Use in Adult Patients Admitted to the Hospital Who are Followed by the Behavioral Response Team

(10-050) Expanding Pharmacy Services Across Outpatient Clinics: A Workflow Document for Injectable Naltrexone Management

(10-051) An Evaluation of the Performance of the Heparin Nomogram for VTE Treatment in Hospitalized Adult Patients

(10-052) Comparison of Healthcare-Associated C. difficile Infection Rates in Patients with Febrile Neutropenia Presenting to the Emergency Department vs Direct Admission to the Oncology Service

(10-053) Implementation of a Collaborative, Pharmacist Driven Pediatric Culture Review Process

(10-054) Improving Postpartum Measles, Mumps, and Rubella Vaccination Rates Through Standardized Workflow Implementation Across a Health System

(10-055) Establishing Guidelines for Implementation of a Vaccine for Children (VFC) Specialty Program in St. Lukes Outpatient Pharmacies: A Quality Improvement Project

(10-056) Metabolic Monitoring Compliance Among Patients Prescribed Second-Generation Antipsychotics at a Federally Qualified Health Center: A Retrospective Cohort Study

(10-057) Real-World Outcomes and Predictors of Success in Helicobacter pylori Eradication: A Retrospective Cohort Study of Test-to-Cure Strategies at a Federally Qualified Health Center

(10-058) A retrospective comparison of argatroban and heparin use in extracorporeal membrane oxygenation patients

(10-059) Evaluating the Impact of Hormonal Therapy Administered to the Potential Organ Donor Following Catastrophic Traumatic Brain Injury

(10-060) Impact of GLP-1 therapy on warfarin requirements in patients with a Left Ventricular Assist Device

(10-062) The Rhythm of Sedation: Comparison of Methohexital, Propofol, and Etomidate for ED Cardioversions

(10-063) Comparison of 1-day vs 2-day Melphalan infusion in adults undergoing Autologous Stem Cell Transplant

(10-064) An evaluation following implementation of a new NORepinephrine concentration in MICU patients admitted for septic shock

(10-065) Fixed vs. Weight-based Prothrombin Complex Concentrate for the Reversal of Direct Oral Anticoagulants in Patients with Intracranial Hemorrhage

(10-066) Safety and Efficacy of Continuous Infusion Bumetanide in Infants ≤44 Weeks Corrected Gestational Age

(10-067) Tolerability of Calaspargase Pegol Compared to Pegaspargase in Patients with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma at a Pediatric Institution

(10-068) Linezolid versus Vancomycin in Patients with Community Acquired Pneumonia and Risk Factors for Methicillin Resistant Staphylococcus Aureus Infection

(10-069) Impact of Dalbavancin on 30-Day Hospital Readmission Rates in Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

(10-070) Impact of Sodium Bicarbonate Administration During In-hospital Cardiac Arrest on Survival to Hospital Discharge

(10-071) Utilization Evaluation of IV Acetylcysteine in Acute Liver Injury: Acetaminophen and Non-Acetaminophen-Induced Etiologies

(10-072) Utilization and Holding Patterns of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors During Inpatient Admission: Analysis of Trends and Comparative Clinical Outcomes

(10-073) Integration of Third Party and Home-Grown Risk Evaluation and Mitigation Strategy (REMS) Content

(10-074) Evaluation of Weight-Based Dosing of Four-Factor Prothrombin Complex Concentrate (4F-PCC) for Warfarin Reversal

(10-075) Pharmacist Led Warfarin Management Consults and Related Interventions in Community Hospital Setting

(10-076) Evaluating Vaccination Compliance in Post-Splenectomy Patients

(10-078) Utilization of the Updated Pediatric Asthma Pathway in Emergency Department in a Community Health System

(10-079) Evaluation of Aprepitant for the Prevention of Postoperative Nausea and Vomiting

(10-080) Evaluation of an Anticoagulant Drug-Drug Interaction Alert System in Pharmacist-Managed Anticoagulation Clinics within a Health System

(10-081) Evaluation of One Year Discontinuation Rates of GLP-1RA and Dual GIP/GLP-1 RAs among Patients with or at Risk for ASCVD in a Pharmacist-Managed Cardio-Diabetes Clinic

(10-082) Evaluating the impact of weekend and “after hours” inpatient chemotherapy initiation to optimize pharmacy workflow

(10-083) Hydroxocobalamin, Methylene Blue or Angiotensin II for Vasoplegia following Cardiothoracic Surgery

(10-084) Review of Prescribed Indications for Concurrent Use of Opioids and Benzodiazepines in Patients Enrolled in Medicare Advantage Plans within a Community Health System

(10-085) Impact of Nebulized Albuterol on Reducing Serum Potassium in Acute Hyperkalemia

(10-086) Evaluation of Oral Vancomycin Prophylaxis for Clostridioides difficile

(10-087) Evaluation of the Continuation of Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) in Hospitalized Patients

(10-088) Evaluation of Argatroban and Bivalirudin Use in Patients with Suspected Heparin-Induced Thrombocytopenia (HIT)

(10-089) Line-Dancing: Weighing Risks and Benefits of Peripheral Vasopressors

(10-090) Optimization of Discharge Antibiotics for Patients with Urinary Tract Infections

(10-091) Ceftriaxone Under the Microscope: A Pharmacist-Driven Approach to Optimize Inpatient Prescribing Practices

(10-092) Enhancing Procedural Area Safety: Implementation of a Narcotic Waste Workflow and Drug Assays in a Community Teaching Hospital

(10-093) Development of a Medication Safety Analytics Dashboard for Smart IV Pump Integration in a Multi-Site Hospital System

(10-094) Evaluation of Current Practices in the Management of Severe Hyponatremia

(10-095) Dual vs. Single Antiplatelet Therapy After Noncardioembolic Ischemic Stroke or Transient Ischemic Attack

(10-096) 4-Factor Prothrombin Complex Concentrate; Weight-based vs Fixed Dosing for Oral Factor Xa Reversal for Intracranial Hemorrhage

(10-097) Dirty or Not: Evaluating the Appropriate Use of Vancomycin and Daptomycin in Possible Blood Culture Contamination

(10-098) Optimizing Enoxaparin Dosing: Outcomes of a Pharmacy Consult Protocol for High-Risk Populations

(10-099) Identifying Patient Characteristics and Service Utilization Patterns for Pharmacist-Provided Test-and-Treat Services in a Participating Chain Supermarket Community Pharmacy Setting

(10-100) Assessing the Impact of the Medicare Prescription Payment Plan on Patient Adherence of Chronic Medications

(10-101) Assessing the Perceived Needs of Illinois Pharmacists for Successful Future Prescribing of Medications for Opioid Use Disorder (MOUD)

(10-102) Safety and Efficacy of Fixed Low-Dose Continuous Infusion Unfractionated Heparin Following Revascularization for Acute Limb Ischemia

(10-103) Evaluating the Administration Timing and Safety of Switching from Alteplase to Tenecteplase in Acute Ischemic Stroke Management

(10-104) Evaluating the Correlation Between Gestational Age and Therapeutic Gentamicin Trough Levels for the Development of a Gestational-Age-Based Dosing Guide

(10-105) Evaluation of Weight-Based Dosing of Propofol and Dexmedetomidine Infusions in Mechanically Ventilated Critically Ill Patients

(10-106) Evaluation of Perioperative Antimicrobial Prophylaxis

(10-107) Safety and Time to Hemodynamic Stabilization of Peripheral vs. Central Vasopressor Initiation: A Single-Center Retrospective Study

(10-108) Management of Opioid Use Disorder in an Urban, Safety Net, Emergency Department

(10-109) Safety of Undiluted Intravenous Push Levetiracetam and Lacosamide

(10-110) Accuracy of Documentation of Urinary Symptoms in Patients with Suspected Urinary Tract Infections

(10-111) Comparison of door-to-needle times with tenecteplase versus alteplase for the treatment of acute ischemic stroke

(10-112) Phenobarbital Dosing Practices in Alcohol Withdrawal: A Retrospective Study of Protocol Use, Additional Dosing, and Associated Outcomes

(10-113) Evaluation of Inpatient Anti-Psychotic De-Escalation Upon Transitions of Care from an Intensive Care Unit Setting

(10-114) Risk Factors for Iatrogenic Opioid Overdose Requiring Naloxone in Hospitalized Adults: A Case-Control Study

(10-115) Oral Fosfomycin for Extended-Spectrum Beta-Lactamases Urinary Tract Infections Managed in the Emergency Department: Dosing Duration, and Outcomes Compared with Standards of Care

(10-116) Evaluation of the Therapeutic Enoxaparin Anti-Xa Monitoring Guideline Utility within the OSF Ministry

(10-117) Comparing the rates of incidence of Necrotizing Enterocolitis and associated morbidity and mortality in Neonatal Patients Receiving Cefotaxime vs Ceftazidime: A retrospective analysis

(10-118) Comparing Safety Profiles of Calaspargase pegol-mknl and Pegaspargase: A Retrospective Analysis of Adverse Events in Acute Lymphoblastic Leukemia Treatment

(10-119) Impact of an inpatient detoxification order set for opioid use disorder in a community hospital

(10-120) Evaluation of Protocol Utilization for Intravenous to Subcutaneous Insulin Transition in Treatment of Diabetic Ketoacidosis: A Retrospective Analysis

(10-121) Comparison of Warfarin Efficacy and Safety in Youngest-Old, Middle-Old, and Oldest-Old Patients with Atrial Fibrillation Enrolled in a Pharmacist-Managed Anticoagulation Clinic

(10-122) Hospitalization Due to Infections After Kidney Transplantation in Patient Living with Human Immunodeficiency Virus (HIV): Incidence, Predictors, and Clinical Outcomes

(10-123) Dose Intensity of Adjuvant Abemaciclib for High-Risk Hormone Receptor Positive Breast Cancer

(10-124) Helicobacter Pylori Order Panel Review

(10-125) Ibuprofen Auto-Verification in High-Risk Populations

(10-126) Haloperidol Decanoate Dose Appropriateness Based on Previous Oral Dosing in an Inpatient Psychiatric Setting

(10-127) Evaluating Use of Tenecteplase for Ischemic Stroke in a Community Hospital

(10-128) Impact of Pharmacist-Led Ambulatory Care Visits for the Optimization of Guideline-Directed Medical Therapy in Patients with Heart Failure with Reduced Ejection Fraction.

(10-129) Establishing a Practical Rule of Thumb for Intravenous Magnesium Sulfate Dosing

(10-130) Evaluating the Compliance of a Nurse-Driven Unfractionated Heparin Infusion Protocol for the Treatment of Venous Thromboembolism

(10-131) The Effect of Norepinephrine’s Timing (early vs. late) on Mortality in Septic Shock

(10-132) Multihospital Evaluation of Barcode Medication Administration and Smart Infusion Pump Compliance for High-Alert Medications

(10-133) Sodium-Glucose Cotransport 2 Inhibitors (SGLT-2i) and Heart failure: Impact on 30-day Readmission through a Pharmacist-Led Quality Improvement Initiative

(10-134) Implementation of Pharmacy Glycemic Management Protocol Changes to Achieve Blood Glucose Levels Between 70-180 mg/dL

(10-135) Intramuscular Site of Injection on Therapeutic Effectiveness of Sedation: A Retrospective Study: IM-SITES

(10-136) Impact of Obesity on Synthetic Angiotensin II Use in Kidney Transplantation

(10-137) Mind the Gap: A Retrospective Analysis of Epinephrine Dosing Interval and Neurological Outcomes.

(10-139) Comparative Risk of Acute Kidney Injury with Trough- vs. AUC-Guided Vancomycin Dosing in Patients with Goal Troughs of 10-15mg/L

(10-140) Blood Pressure Reduction and Clinical Outcomes Following as Needed Antihypertensive Medication Administration in General Medicine Patients

(10-141) Intravenous Immunoglobulin (IVIG) for Treatment of BK Viremia in Kidney Transplant

(10-142) Analyzing the Efficacy and Safety of Sodium Glucose Co-Transporter 2 Inhibitors Initiated Within the First Year After Kidney Transplantation

(10-143) Pediatric Immunization Uptake and Social Determinants of Health

(10-144) The Effects of Mycophenolic Acid Load on Leukopenia in Obese versus Non-obese Kidney Transplant Recipients

(10-145) Evaluating Patient Retention Rates in a Health System Specialty Pharmacy

(10-146) Impact of Teduglutide on Hospital Readmissions Among Patients with Short Bowel Syndrome at the University of Illinois Hospital & Health Sciences System

(10-147) Mycophenolate Avoidance Following Kidney Transplant in Patients that Identify as Jehovah's Witness

(10-149) Adverse Effects of Endemic Dimorphic Fungi Treatments; Before vs After IDSA's 2025 Histoplasmosis / Blastomycosis Guideline Update

(10-150) Beyond the Pulse: Belatacept’s Impact on Allograft Function in Circulatory vs. Brain Death Kidney Transplants

(10-151) Evaluation of Guideline-Compliant Empiric Antibiotic Regimens in Emergency Department Patients with Severe Sepsis or Septic Shock

(10-152) Comparing Thymoglobulin Dosing Strategies and Clinical Outcomes in Renal Transplantation: A Retrospective Cohort Study

(10-153) Effects of Early Corticosteroid Withdrawal in Sensitized Kidney Transplant Recipients

(10-154) o Enhancing Patient Access to Manufacturer Financial Assistance Programs for Ambulatory Infused Medications: A Quality Improvement Initiative at a Single Community Hospital

(10-155) Evaluation of Discontinuation Rates of Incretin-Based Pharmacotherapy in Type 2 Diabetes: Pharmacist vs. Standard of Care Management

(10-156) Evaluation of Transient Acute Kidney Injury Rates Among Critically Ill Patients

(10-157) Evaluation of Insulin Transition Practices for Diabetic Ketoacidosis Management in a Community Hospital

(10-158) Impact of Pharmacist-Led Education on Buprenorphine Initiation for Opioid Use Disorder in a Community Emergency Department

(10-159) Evaluating Safety Outcomes Following Implementation of Warnings for No Guardrails Infusions in Smart Pumps in Hospital Settings

(10-160) Assessing the Incidence of Venous Thromboembolism and Prophylaxis Patterns in Adult Patients Diagnosed with High Risk Cancer Types

(10-161) Impact of Automatic Stop Dates on Community-Acquired Pneumonia Treatment

(10-162) Implementation of a Health-System Retail Pharmacist Transitions of Care Service in a Safety-Net Health System

(10-163) Evaluating Pharmacy Policies and Effectiveness by Way of Pharmacist Peer Review Over a Specific Time Frame

(10-164) Evaluation and Optimization of Inhaled Respiratory Medication Use in a Regional Hospital

(10-165) Comparing time to therapeutic activated partial thromboplastin level versus anti-Xa level in patients on intravenous unfractionated heparin.

(10-166) Evaluating Provider Productivity and Reimbursement in a Provider-Pharmacist Co-visit Model Compared to Pharmacist-Only Visits for Medicare Annual Wellness Visits

(10-167) Optimizing Urinary Antigen Testing for Legionella Using Clinical Predictors to Improve Test Utilization in Community-Acquired Pneumonia Admissions

(10-168) Evaluation of Pharmacist Impact in Healthy Aging Transition Services (HATS)

(10-169) Optimizing Therapy for ESBL and AmpC Bacteremia: A Comparison of Ertapenem and Meropenem

(10-170) Difference in Length of Hospitalization between Risperidone Extended-Release Injection versus Paliperidone Palmitate

(10-171) Phenobarbital Dosing Strategy in Alcohol Withdrawal Syndrome

(10-172) Evaluation of Atropine Premedication on Acute Irinotecan-Related Adverse Effects (IRAEs)

(10-173) Anabolic Agent Use in Osteoporosis: The Role of Pharmacist Involvement and Health System Cost Analysis

(10-174) Evaluating the Prescribing Patterns of Antiplatelets After Acute Coronary Syndrome (ACS) at Community Health Network (CHNw)

(10-175) Implementation of a Best Practice Advisory for Ordering of Sodium-Glucose Cotransporter 2 Inhibitors: Impact on Clinical Outcomes in Hospitalized Patients

(10-176) The Evaluation of Clozapine Prescribing Practices and Impact on Access Pre- and Post-REMS Removal

(10-177) Evaluation of ethnoracial disparities in management of addiction medicine and palliative care patients

(10-178) Risk Factors for Drug-Resistant Pathogens in Community-Acquired Pneumonia: A Retrospective Evaluation of Predictors, Empiric Antibiotic Use, and Stewardship Opportunities

(10-179) Clinical and Pharmacoeconomic Profile of Heparin Infusion and Enoxaparin: A Comparative Observational Study

(10-180) Desirability of Outcome Ranking (DOOR) Analysis of Cefpodoxime vs Ciprofloxacin for definitive oral step-down therapy in patients with gram-negative bacteremia

(10-181) Assessment of Real-World Utilization of Early Dual Antiplatelet Therapy in Acute Mild Ischemic Stroke

(10-182) Clinical Significance of Minimum Inhibitory Concentrations of Aminopenicillins in Oral Stepdown Therapy of Gram-Negative Bacteremia

(10-183) Evaluating the Effect of Trimethobenzamide Administration on QTc Prolongation

(10-184) Outcomes of Cefepime 30-Minute Intermittent Infusion vs 4-Hour Extended Infusion

(10-185) Clinical Impact of Virtual Pharmacist-Managed Heart Failure with Remote Patient Monitoring

(10-186) Effects of acute corticosteroid use in community acquired pneumonia

(10-187) Efficacy of Electrolyte Replacement by Provider versus Protocol

(10-188) Evaluation of Pharmacist Impact on Correct Route of Medication After Cerebral Vascular Accident (CVA)

(10-189) Impact of Multiplex Molecular Panel De-Implementation on Clinical and Antimicrobial Stewardship Outcomes in Patients with Bloodstream Infections

(10-190) Clinical Outcomes Before and After Transition in 4-Factor Prothrombin Complex Concentrate Utilization for DOAC Reversal in Major Bleeding

(10-191) Comparing the Effectiveness of Loading Dose Levetiracetam in the Emergency Department: A Multi-Center Retrospective Study

(10-192) Impact of Universal Mupirocin Decolonization on MRSA Pneumonia Incidence in ICU patients

(10-193) Impact of clinical digital assessments on patient engagement and clinician administrative burden​

(10-194) Impact of Specialty Pharmacy Operational Metrics on Patient Clinical Adherence Outcomes

(10-195) A Centralized Utilization Management Model’s Impact on Medication Access

(10-196) No CAP! Evaluation of Empiric Antibiotic Duration for Community-Acquired Pneumonia

(10-197) Comparison of Hypertension Outcomes in Pharmacist Managed Patients versus Cardiology Provider-Only Care Models

(10-198) Stool Rules: Evaluation of Fidaxomicin Use Before and After Formulary Addition and Implementation of Use Criteria

(10-199) Evaluation of Corticosteroid Use in Pediatric Patients With Bronchiolitis

(10-200) Catch Flights, Not RSV: Real-World Evaluation of Respiratory Syncytial Virus (RSV) Vaccine Use in Maternal and Older Adult Populations

(10-201) Naloxone Addition to the Nursing Admission Order Set: A Retrospective Review

(10-202) Evaluating a Clinical Pharmacist’s Role at a Graduate Medical Education Primary Care Residency Clinic

(10-203) Pharmacist-Driven Optimization of Guideline-Directed Medication Therapy (GDMT) in Heart Failure with Reduced Ejection Fraction (HFrEF)

(10-204) Evaluation of Inpatient Use of Tbo-Filgrastim

(10-205) Evaluation of the Utilization and Appropriateness of Chemotherapy Antiemetic Premedications

(10-206) Therapeutic Stability of Penicillin G Potassium, Gentamicin, Ceftiofur, Oxytetracycline, Florfenicol, and Enrofloxacin in Plastic Syringes

(10-207) Assessment of Pharmacists’ Impact on Piperacillin/Tazobactam Utilization for Intra-Abdominal Infections in a Community Hospital Setting

(10-208) Evaluation of the Efficacy of Ropivacaine Cocktail versus Single Liposomal Bupivacaine Injection in Elective Hip or Knee Replacement Surgeries in a Community Hospital Setting

(10-209) Assessing the Impact of Inpatient-to-Outpatient Heart Failure Clinic Transitions of Care on Patient Safety

(10-210) Evaluating the Prevalence of Multiple Anticholinergic Medication Use in Older Adults Utilizing POLY-ACH Criteria

(10-211) Efficacy of Lorazepam vs First Generation Antipsychotics with Lorazepam for Emergency Department Management of Methamphetamine-Associated Acute Agitation

(10-212) Safety Profile of Vancomycin vs Daptomycin for Skin and Soft Tissue Infections in Morbidly Obese Patients

(10-213) Basal Burden: Risk Factors for Overbasalization in Type 2 Diabetes Mellitus in Primary Care

(10-214) Sildenafil vs Tadalafil with Endothelin Receptor Antagonists in Pulmonary Hypertension: Meta-Analysis of Hemodynamic Outcomes

(10-215) Incidence of Thromboembolic Events in Patients on Edoxaban with Estimated Creatinine Clearance > 95 mL/min

(10-216) Evaluation of Oral Anticoagulant Prescribing Practices in a Tertiary Care Academic Medical Center: A Retrospective Study

(10-217) Evaluation of a Pharmacist-Led Application of the IMPEDE VTE Score in Multiple Myeloma Patients at a Lebanese Tertiary Medical Center: A Retrospective Study

(10-218) Description and analysis of severe interactions detected in oncological and hematological patients undergoing active treatment

(10-219) Successful Stepwise Omalizumab Withdrawal after Long-Term Dual Therapy with Benralizumab in Severe Asthma with Allergic Bronchopulmonary Aspergillosis and Corticosteroid Dependence: A Case Report

(10-220) Use of Antineoplastic Treatment in Oncology Patients at the End of Life: A Retrospective Analysis

(10-221) Eculizumab: Assessing Adherence to Hospital Guidelines and Treatment Outcomes

(10-222) Development of a Polypharmacy Management System for Medication Review and Counseling in Elderly Patients

(10-223) Compliance of Potassium Chloride (KCl) Replacement with Hospital Guidelines in the Emergency Department

(10-224) Outcomes of Amphotericin B, Azoles, and Echinocandins in Candidemia: A 3- Year Retrospective Study from a Quaternary Care Hospital in Pakistan

(10-225) Effectiveness and safety of Angiotensin receptor/neprilysin inhibitors compared with sodium-glucose cotransporter-2 inhibitors in patient with heart failure and reduced ejection fraction

(10-226) The Hidden Consequence: Hypoglycemia Induced by Hyperkalemia Therapy

(10-227) Evaluation of the Enoxaparin Use During Perioperative Warfarin Interruption at Mercy Anticoagulation Clinic

(10-228) Evaluation of Clinical Pharmacist Review of Emergency Department Discharge Antibiotic Prescriptions at a Community Hospital

(10-229) Glucocorticoid Utilization in Severe Sepsis and Septic Shock

(10-230) Optimization of Autoverification Process in the Emergency Department

(10-231) Evaluation of Guideline-Directed Medical Therapy Prescribing and Optimization Practices for Admitted Patients with Heart Failure with Reduced Ejection Fraction

(10-232) Improving Compliance and Competency in USP <800> Hazardous Drug Handling Through Surveys, Direct Observation, and Structured Pharmacy Staff Training

(10-233) Patient Response at Time of Surgery After Paclitaxel-Related Infusion Reactions in Triple-Negative Breast Cancer (TNBC): a Retrospective Review

(10-234) Evaluating the Impact of Sedation Levels on Patient Outcomes in the Intensive Care Unit

(10-235) Evaluation of Epidural Analgesia and Hypotension in Obstetrics

(10-236) Evaluation of Appropriate Guideline-Directed Medical Therapy Usage in Heart Failure with Reduced Ejection Fraction Upon Hospital Discharge

(10-237) Retrospective Chart Review of Syphilis Screening in the ED and Inpatient Management from July 2021 – June 2025

(10-238) Evaluation of Appropriate Guideline-Directed Medical Therapy Usage in Heart Failure with Preserved Ejection Fraction Upon Hospital Discharge

(10-239) Evaluation of Fidaxomicin Usage on Clostridioides difficile Infection (CDI) in a Tertiary Care Teaching Hospital

(10-240) Utilization of Amoxicillin Oral Challenge Protocol in a Community Hospital Emergency Department

(10-241) Evaluating Guideline-Directed Medical Therapy Optimization in Patients with Heart Failure at an Ambulatory Clinic

(10-242) Colorectal Cancer Screening Through Pharmacies in Rural Communities

(10-244) Safety and Efficacy of Direct Oral Anticoagulants (DOACs) in Patients with Obesity

(10-245) Impact of Medication Use Evaluation Education on Gentamicin Trough Monitoring Practices in Neonates: A Pre-Post Study

(10-246) Efficacy of 300 mg/day Versus 200 mg/day IV Hydrocortisone in Time to Resolution of Septic Shock

(10-247) Midodrine for Persistent Hypotension in Reduced Versus Normal Ejection Fraction in Cardiac Surgical Patients

(10-248) Fixed vs. Weight-based Prothrombin Complex Concentrate for the Reversal of Direct Oral Anticoagulants in Patients with Intracranial Hemorrhage

(10-249) Evaluation of Continuous Glucose Monitors for Glycemic Evaluation and Screening of Cystic Fibrosis-Related Diabetes

(10-250) Beyond Clinical Outcomes: The Operational and Financial Benefits of Insulin Lispro in Hyperkalemia Protocols

(10-251) Effect of a Single Initial Therapeutic Anti-Xa Level on Patient Therapeutic Range during Heparin Therapy in a Community Hospital

(10-252) Evaluation of Gastrointestinal Bleeding Incidence in Patients who are Prescribed Oral NSAIDs after Total Knee or Hip Arthroplasty in a Community Hospital Setting

(10-253) Post-implementation analysis of weight-based vasopressors versus fixed-rate vasopressors

(10-254) Outcomes Analysis of Pharmacy-Guided De-escalation from Intravenous Ceftriaxone in Gram-negative Urine Cultures

(10-255) Applying Define, Measure, Analyze, Improve, and Control (DMAIC) to Optimize Medication Kits in a Community Hospital

(10-256) From Door to Discharge: Evaluating Pharmacist Involvement in ST-Segment Elevation Myocardial Infarction (STEMI) Patient Management at a Community Teaching Hospital

(10-257) Optimizing Hyponatremia Management: Insights from a Community Teaching Hospital

(10-258) Empiric Vancomycin Use in Surgical Site Infection Cases Without Methicillin-Resistant Staphylococcus aureus Risk Criteria in the Emergency Department

(10-259) Analysis of Post-operative Infections in Elective Cardiothoracic Surgeries after the Elimination of Routine Pre-operative Urinalysis

(10-260) Comparative Effect of Weight-Based Versus Fixed Dose Iron Supplementation on Hematocrit Levels in Preterm Neonates

(10-261) Effect of Obesity on Incidence and Severity of Neurotoxicity in Patients Receiving Arsenic Trioxide for Acute Promyelocytic Leukemia

(10-262) Comparing the Clinical Efficacy of Higher versus Lower Valproic Acid Maintenance Dosing in Status Epilepticus

(10-263) Intravenous or Intramuscular Lorazepam versus Intravenous or Intramuscular Diazepam in Acute Alcohol Withdrawal: Medication Use Evaluation

(10-264) Evaluation of transdermal clonidine prescribing practices for dexmedetomidine weaning in pediatric patients at an academic medical center

(10-265) Evaluating Incidence of Immune Effector Cell-Associated HLH (IEC-HLH) Across CAR-T and BiTE Therapies

(10-266) Real Life Effect of Biologic Therapy Initiation in Cumulative Non-Inhaled Corticosteroid Use for Asthma Control at a Single Academic Medical Center

(10-267) Efficacy and Safety of Low-Dose Anti-Thymocyte Globulin Compared to Moderate-Dose Anti-Thymocyte Globulin for Induction Therapy in Kidney Transplantation

(10-268) Evaluation of Restrictions for Lipid Emulsion (Soy-Olive-Fish-Triglyceride) SMOFlipid

(10-269) Evaluation of the Safety and Efficacy of Antimotility Agents in Patients with Clostridiodes difficile Infection

(10-270) Clinical Utility and Economic Impact of Remimazolam for Procedural Sedation at a Large Academic Medical Center

(10-271) Effectiveness of Off-Label Increased Dosing of Omalizumab Compared to Standard Dosing for Chronic Spontaneous Urticaria

(10-272) Comparison of Clinical Outcomes Between Oral Fluoroquinolones and Trimethoprim-Sulfamethoxazole Versus Oral Beta-Lactams for Uncomplicated Enterobacterales Bloodstream Infections

(10-273) Evaluating the Y-Site Compatibility of Blinatumomab

(10-274) Incidence and Risk Factors for Hypokalemia or Hypophosphatemia in Adult Inpatients on Scheduled Electrolyte Lowering Therapy​

(10-275) Nudging the Path: Infectious Diseases Consults in Staphylococcus aureus Bacteremia

(10-276) Evaluation of Seizure Prophylaxis for Traumatic Brain Injury

(10-277) Paclitaxel titration and its impacts on hypersensitivity reactions

(10-278) Current Practices for Storage of Hyperosmolar 23.4% NaCl in Critical Care Settings: A Multicenter Survey Study in US

(10-279) Integrating Pharmacists into the Primary Care Team

(10-280) Emergency Medicine Pharmacist Antibiotic Discharge Optimization for UTI and Pneumonia

(10-281) Implementation of a Pharmacist-Managed Mavacamten Clinic

(10-282) Implementation of Age-Appropriate Medication Recommendations in Patients 65 Years and Older Within a Health System

(10-283) Implementation of Prescriber Antibiotic Scorecards in a Rural Community Hospital

(10-284) Evaluation of the Rates of Hypoglycemia and Potassium-lowering Effects of Insulin Pre- and Post-implementation of Renally-adjusted Insulin within a Hyperkalemia Order Set.

(10-285) Assessment of GOLD Guideline Adherence at Discharge and Its Association with COPD Readmissions in a Rural Health System

(10-286) Impact of Education on Subcutaneous Electronic Glucose Management System Usage in a Community Hospital

(10-287) Impact of Provider Education on Adherence to a Urine Culture Guidance Algorithm in a Community Hospital

(10-288) Impact of Pharmacist Education on Opioid Stewardship Interventions in a Community Hospital

(10-289) Evaluating the Impact of Provider Education on Empiric Antibiotic Use for Low-Risk Intra-Abdominal Infections at a Community Hospital

(10-290) Impact of a Risk-Assessment SmartPhrase on Diagnostic Evaluation for Cardiac Amyloidosis in a Heart Failure Clinic

(10-291) Predictors of Incomplete Guideline-Directed Medication Therapy Initiation at Hospital Discharge in Patients with Heart Failure with Reduced Ejection Fraction

(10-292) Effect of Intravenous Sodium Bicarbonate on ICU Mortality in Critically Ill Patients with Acute Kidney Injury and Metabolic Acidosis

(10-293) Impact of Pharmacist Presence on Time to Post-Intubation Sedation in Emergency Department Patients Receiving Rocuronium for Rapid Sequence Intubation (RSI)

(10-294) Clinical Outcomes of Using Cefdinir Versus Other Beta-Lactams for Oral Transition Therapy in Community Acquired Pneumonia

(10-295) Helpful or Harmful: A Retrospective Review of Medication Hold Orders

(10-296) Increasing Pharmacist Utilization of Electronic Medical Record-Based Pharmacist Documentation Tools to Provide Defect-Free Care in Acute Coronary Syndrome and Stroke

(10-297) Impact of Emergency Department Pharmacist Presence on Time to Antibiotic Administration in Patients with Sepsis at a Rural Community Hospital

(10-298) Impact of a National Fluid Shortage on Patient Outcomes in an Academic Community Hospital- A Retrospective Observational Study

(10-299) Improving Emergency Department Cessation of Status Epilepticus: The Role of Weight-Based Intravenous Levetiracetam Dosing

(10-300) Time-to-Positivity of Blood Cultures in Early-Onset Sepsis in the Neonatal Intensive Care Unit

(10-301) Evaluating impact of concentration change on time to administration of intravenous (IV) levetiracetam and lacosamide for pediatric seizures

(10-302) Evaluation of Hypoglycemic Events Following Diabetic Ketoacidosis Protocol Updates

(10-303) Evaluation of Rabies Post-Exposure Prophylaxis at a Regional Health System

(10-304) Impact of CYP2D6, CYP1A2, and Smoking on Duloxetine Discontinuation

(10-305) Impact of CYP2D6 Genotype on Opioid Efficacy and Tolerability

(10-306) Evaluation of Time to Therapeutic Range in Pre- and Post-Implementation of Vancomycin Area Under the Curve Dosing Protocol

(10-307) Optimizing Alcohol Withdrawal Syndrome Treatment: Retrospective Comparison of Benzodiazepine Monotherapy versus Benzodiazepine with Adjunctive Phenobarbital

(10-308) Short versus Long Duration of Antibiotic Therapy for Patients with Uncomplicated Gram-Negative Bacteremia: A Comparative Retrospective Study

(10-309) Evaluating the Impact of Treatment Plans on Laboratory Monitoring in Oral Oncolytic Regimens

(10-310) Pre-Operative Antibiotic Ordering with Electronic Medical Record (EMR) Updates on Allergy Documentation

(10-311) Impact of Pharmacist-Led Discharge Interventions on Patient Outcomes After Percutaneous Coronary Intervention (PCI)